Cytomx Therapeutics, Inc. (CTMX)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

19

0

6

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
22-Aug-24 6:00 PM View:	20-Aug-24 Option Sale ($5.14K)	Rowland Lloyd A General Counsel		Cytomx Therapeutics, Inc. - CTMX	44% 90.82K to 130.8K	0	0	--	--	Show Txns Hide Txns

22-Aug-24 5:58 PM View:	20-Aug-24 Option Sale ($17.08K)	McCarthy Sean A. CEO Director		Cytomx Therapeutics, Inc. - CTMX	43% 523.91K to 751.01K	0	0	--	--	Show Txns Hide Txns

22-Aug-24 6:01 PM View:	20-Aug-24 Option Sale ($5.14K)	Belvin Marcia SVP, Chief Scientific Officer		Cytomx Therapeutics, Inc. - CTMX	19% 147.95K to 175.65K	0	0	--	--	Show Txns Hide Txns

19-Jan-24 8:37 PM View:	18-Jan-24 Grant 0	Chu Yu-Waye Chief Medical Officer		Cytomx Therapeutics, Inc. - CTMX	100% 0 to 26.25K	0	0	--	--	Show Txns Hide Txns

22-Aug-24 6:01 PM View:	20-Aug-24 Option Sale ($5.14K)	Landau Jeffrey B Chief Business Officer		Cytomx Therapeutics, Inc. - CTMX	45% 87.13K to 126.74K	0	0	--	--	Show Txns Hide Txns

22-Aug-24 5:59 PM View:	20-Aug-24 Option Sale ($2.44K)	Ogden Christopher Chief Financial Officer		Cytomx Therapeutics, Inc. - CTMX	147% 43.77K to 108.08K	0	0	--	--	Show Txns Hide Txns